A 63-year-old female and a 63-year-old male with resolved HBV infection suffered a relapse of malignant lymphoma. After bendamustine hydrochloride monotherapy, HBV reactivation occurred. Entecavir treatment was commenced immediately, with tests for HBV DNA negative without development of hepatitis. Regular monitoring of HBV DNA based on the guidelines from the Japan Society of Hepatology was useful.
|ジャーナル||Journal of Japanese Society of Gastroenterology|
|出版ステータス||出版済み - 9 2016|
All Science Journal Classification (ASJC) codes